Genentech announced that new data were presented at the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s ...

Song, M.D., Chairman and Chief Executive Officer of NKGen, will present at the International Conference on Alzheimer's and ... Phase 1/2a clinical trial for troculeucel NK cell therapy in moderate ...

Kassim Javaid, Professor of Osteoporosis and Adult Rare Bone Diseases and lead investigator of the ADOPT study, will present expanded data from the study showcasing the clinical utility of the AI ...

Lansing housing officials present data from a 2023 study done on homelessness in the city ...

Longhorn Vaccines and Diagnostics is a closely held One Health company based in Maryland that is developing broad coverage vaccines and diagnostic tools for worldwide public health concerns such ...

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS), a clinical-stage biopharmaceutical company, is set to showcase significant advancements in its treatments for Alzheimer’s disease (AD) and Parkinson’s ...

* In July 2021, Innovent and Ascentage Pharma (6855.HK) reached the agreement regarding the joint development and commercialization of olverembatinib in China. Dr. Kaijie He, Vice President of ...

Dr. Sarah-Jane Neuberth will present preclinical findings on HDP-201, Heidelberg Pharma´s novel Exatecan-based, multimeric linker ADC, called ETAC technology, which is being developed for the ...

Evaxion will present new biomarker and immune data obtained from the ongoing phase 2 trial. These will further add to EVX-01’s already strong clinical data package. “We are proud to be ...

today announced it will present new clinical data from its OVERTURE study at the AD/PD 2025 International Conference on Alzheimer's and Parkinson's Diseases, taking place April 1-5, 2025 ...